The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus

Conditions: Fatty Liver, Nonalcoholic Interventions: Drug: SGLT2 inhibitor Sponsors: Sohag University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials